Test Bank For Pathophysiology: A Practical Approach 4th Edition By Lachel Story 9781284205435 Chapter 1- 14 Complete Guide .

,Pathophysiology: nnA nnPractical nnApproach: nnA nnPractical nnApproach
nn nn nn nn nn nn



nn4th nnEdition nnStory nnTest nnBank
nn nn nn nn nn




Chapter nn1 nnCellular nnFunction
nn nn nn




nn 1.
nn An nnincrease nnin nncardiac nnsize nnand nnfunction nndue
nn nn nn nn nn nn nn



nnto nnincreased nnworkload nnis nntermed
nn nn nn nn nn




A) Atrophy.
B) Functional.
C) Hypertrophy.
D) Inflammation.




nn 2.
nn While nnassessing nna nnpatient nndiagnosed nnwith nnMarfan's
nn nn nn nn nn nn



nnSyndrome, nnthe nnnurse nnshould
nn nn nn nn




include nnwhich nnof nnthe nnfollowing nnthat nnis nnconsistent nnwith
nn nn nn nn nn nn nn nn



nnthe nnsyndrome?
nn nn




A) Cardiac nnassessment nnfor nncoarctation nnof nnthe nnaorta.
nn nn nn nn nn nn




B) Genital nnassessment nnfor nnsmall nntesticles.
nn nn nn nn




C) Mental nnassessment nnfor nnimpairment.
nn nn nn

,D) Oral nnassessment nnfor nncleft nnpalate.
nn nn nn nn




nn 3.
nn Children nnwith nnPKU nnmust nnavoid nnphenylalanine nnin
nn nn nn nn nn nn



nnthe nndiet. nnPhenylalanine nnis nnmost
nn nn nn nn nn




likely nnto nnbe nna nncomponent nnof
nn nn nn nn nn




A) Fat.
B) Sugar.
C) Protein.
D) Carbohydrate.




nn 4.
nn A nn17-year-old nncollege-bound nnstudent nnreceives nna
nn nn nn nn nn



nnvaccine nnagainst nnan nnorganism nnthat
nn nn nn nn nn




causes nnmeningitis. nnThis nnis nnan nnexample nnof
nn nn nn nn nn nn




A) primary nnprevention.
nn




B) secondary nnprevention. nn




C) tertiary nnprevention.
nn




D) disease nntreatment.
nn




nn nn 5. Metaplasia nnis nn




A) The nndisorganization nnof nncells nninto nnvarious nnsizes, nnshapes,
nn nn nn nn nn nn nn



nnand nnarrangements.
nn nn




B) The nnreplacement nnof nnone nndifferentiated nncell nntype nnwith
nn nn nn nn nn nn nn



nnanother.
nn

, C) The nntransformation nnof nna nncell nntype nnto nnmalignancy.
nn nn nn nn nn nn nn




D) An nnirreversible nncellular nnadaptation.
nn nn nn




nn nn
nn 6.
nn During nna nnroutine nnultrasound nnof nna nn38 nnyear nnold
nn nn nn nn nn nn nn nn



nnwomen nn26 nnweeks nngestation nnreveals nna nnfetus nnwith nna
nn nn nn nn nn nn nn nn nn



nnsmall nnsquare nnhead, nnupward nnslant nnof nnthe nneyes, nnand
nn nn nn nn nn nn nn nn nn



nnlow nnset nnears. nnThe
nn nn nn nn




nurse nnrecognizes nnthat nnthese nnfindings nnare nnconsistent nnwith
nn nn nn nn nn nn nn



nnwhich nnof nnthe nnfollowing?
nn nn nn nn




A) Fragile nnX nnSyndrome. nn nn




B) Monosomy nnX nn(Turner's nnSyndrome). nn nn nn




C) Trisomy nn21 nn(Down's nnSyndrome).
nn nn nn




D) Trisomy nnX nn(Klinefelter's nnSyndrome).
nn nn nn




nn 7.
nn While nndiscussing nntreatment nnoptions nnwith nna nnparent
nn nn nn nn nn nn



nnof nna nnnewly nndiagnosed nnMonosomy
nn nn nn nn nn




X nn(Turner's nnSyndrome) nnchild, nnthe nnnurse nnshould nninclude
nn nn nn nn nn nn nn



nnwhich nnof nnthe nnfollowing?
nn nn nn nn




A) There nnis nnno nntreatment nnor nncure.
nn nn nn nn nn




B) Symptoms nnof nnthe nncondition nnare nntreated nnwith nnestrogen.
nn nn nn nn nn nn nn




C) Symptoms nnof nnthe nncondition nnare nntreated nnwith
nn nn nn nn nn nn



nntestosterone.
nn




D) Institutionalization nnis nnthe nnpreferred nnmethod nnof nnmanaging nn nn nn nn nn nn



nncare.
nn